Search News Archives
Follow us on
Conferences | Events
Media Partners

NovAliX and Pierre Fabre Partner to Provide Access for NovAliX’ Clients to Pierre Fabre’s Extensive Library of Original Fragments Isolated from Plants

publication date: May 16, 2018
 | 
author/source: Pierre Fabre

pierre fabreNovAliX, a trusted provider of expert chemistry and biophysics services with cutting-edge screening techniques, will broaden the range of clients to access the bio-derived structurally diverse fragments of the Natural Fragment Library.

Thanks to the Natural Fragment Library, the entire supply chain for the molecular fragments from Pierre Fabre plant library is kept under control - from fully traceable plant sourcing, to production and supply in compliance with  biodiversity access regulations
 
NovAliX, a trusted provider of expert chemistry and biophysics services with cutting-edge screening techniques, and Pierre Fabre, the second largest dermo-cosmetics laboratory in the world, has announce that they have entered into a partnership to make the Pierre Fabre ‘Natural Fragment Library’ (NFL) available for use in biophysical methods and screening techniques developed and offered by NovAliX.
 
In line with its Open Innovation initiative, Pierre Fabre aims to reach a wide audience with its fragment library. To achieve this while staying focused on their field of expertise, Pierre Fabre Laboratories decided to collaborate with NovAliX, an international partner specialized in drug discovery and biophysics-based screening and characterization services. This cooperation will allow NovAliX to grant access to the Pierre Fabre NFL to its clients (pharmaceutical laboratories, biotechnology institutions and companies) for their screening projects.
 
“Fragment-based screening, an emerging field, offers valuable prospects for identifying promising candidates for drug discovery. With the Natural Fragment Library, our new Open Innovation initiative, we have decided to give access to our library of fragments, offering a high level of originality and interesting chemical properties due to their natural origin. These fragments come from our plant collection, the largest private collection in the world in terms of size and diversity,” said Frédéric Duchesne, president & CEO, Pierre Fabre Médicament (Pharmaceutical).
 
“NovAliX continues to evaluate technologies and collaborations to complement its current capabilities. The Pierre Fabre Natural Fragment Library is a great addition and alternative to our small molecule  micro-array SPR platform. The chemical diversity of natural fragments combined with our biophysical capabilities is a smart mix for initiating structurally enabled drug discovery programs,” said Denis Zeyer, PhD, CEO of NovAliX.


more about pierre fabre




 

Popular this month


 

Lose the Solvent Headache with Cole-Parmer VapLock™ Closed Systems


Tomocube adds 3D Fluorescence Imaging to Holotomography Microscopy for World First


ZEISS Elyra 7 with Lattice SIM IntroducedZEISS Elyra 7 with Lattice SIM Introduced


Restek Now Has Even More of What You Need to Keep Your LC Flowing


Metrohm contributes to global monograph modernization initiative


Fused-Core Selectivity Toolkits for Superficially-Porous Particle Method Development


Introducing Renishaw’s New RA816 Biological Analyser


ID Kit – fast, easy, and accurate detection of heroin and other illicit drugs


Safe Evaporative Sample Preparation of High Potency APIs


Simplifying high content screening with the VIAFLO 96

 

 

Can't find what you are looking for?


Search by company or by product


Company Name:

Product:





Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd
Media Partners